Logo image
Dynamic Connectedness among Vaccine Companies’ Stock Prices: Before and after Vaccines Released
Journal article   Open access   Peer reviewed

Dynamic Connectedness among Vaccine Companies’ Stock Prices: Before and after Vaccines Released

Kazi Sohag, Anna Gainetdinova, Shawkat Hammoudeh and Riad Shams
Mathematics (Basel), v 10(15), p2812
01 Jan 2022
url
https://doi.org/10.3390/math10152812View
Published, Version of Record (VoR)CC BY V4.0 Open

Abstract

Behavior Coronaviruses COVID-19 vaccines Disease transmission Economic crisis Emerging markets Financial institutions Immunization International finance Investments Natural gas prices Pandemics Pharmaceutical industry Portfolio management Quantiles Securities markets Stock exchanges Vaccines Volatility
This study investigates the interconnectedness among the stocks of the publicly listed vaccine-producing companies before and after vaccine releases in 2020/21. In doing so, the study utilizes the daily frequency equity returns of the major vaccine producers, including Moderna, Pfizer, Johnson & Johnson, Sinopharm and AstraZeneca. First, the investigation applies the TVP-VAR Dynamic Connectedness approach to explore the time–frequency connectedness between the stocks of those vaccine producers. The empirical findings demonstrate that Moderna performs as the most prominent net volatility contributor, whereas Sinopharm is the highest net volatility receiver. Interestingly, the vaccine release significantly increases the stock market connectedness among our sampled vaccine companies. Second, the cross-quantile dependency framework allows for the observation of the interconnectedness under the bearish and bullish stock market conditions by splitting any paired variables into 19 quantiles when considering short-, medium- and long-memories. The results also show that a high level of connectivity among the vaccine producers exists under bullish stock market conditions. Notably, Moderna transmits significant volatility spillovers to Sinopharm, Johnson & Johnson and AstraZeneca under both the bearish and bullish conditions, though the volatility transmission from Moderna to Pfizer is less pronounced. The policy implication proposes that the vaccine release allows companies to increase their stock returns and induce substantial volatility spillovers from company to company.

Metrics

8 Record Views
4 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#8 Decent Work and Economic Growth

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
International collaboration
Web of Science research areas
Mathematics
Logo image